Data, Architectural Engineering, and Designing a Better Future
Proof in Trial: Appellate Edition: Integra Med Analytics LLC et al. v. Providence Health & Services et al.
Compliance Perspectives: The Ethics of Data
Life With GDPR: Episode 50-The Experian Enforcement Notice Case
JONES DAY PRESENTS®: AI: Security and Privacy Risks with Big Data
31 Days to a More Effective Compliance Program -The Compliance Advantage of Data
6 Key Takeaways | The Chinese Social Credit System
Innovation in Compliance Live: Revamping Your Swing with Data Analytics and AI
Podcast: Common Risks and Challenges in Running a Global Ethics & Compliance Program
SEC Activity with Fixed Income and Credit Funds
Innovation in Compliance Episode 17: Compliance in the Age of Big Data with Alexander Tsigutkin and Varun Singhal
The Intersection of Big Data and Insurance Regulation
InsurTech and the Changing Distribution Model
Blockchain Technology Applications for the Insurance Industry
What’s Next?: Drones and transforming policy at GE
Employment Law This Week®: Big Data and People Analytics
Government data mining leads to more aggressive investigations
This Week in FCPA-Episode 74
Episode 23: Using “People Analytics” to Make Smart Business and Corporate Culture Decisions
Changing values of IP and data in deals
In November, McDermott Will & Emery was pleased to host our annual European Health & Life Sciences Symposium in Paris. Welcoming a large crowd of healthcare professionals, investors and dealmakers for a programme of...more
Clinical trials have become increasingly important for pharmaceutical companies and medical device manufacturers, which are focused on collecting as much data as possible on products and devices and their adverse effects. All...more
On October 22, 2019, Skadden hosted our Ninth Annual Pharmaceutical and Medical Device Enforcement and Litigation Seminar in New York, which focused on U.S. enforcement issues companies face throughout the industry. The key...more
Discoveries advance on a regular basis as to how cannabidiol and related therapeutics can heal or at least relieve the pain associated with health conditions. From cancer and opioid addiction to chronic pain and glaucoma,...more
A confluence of factors is increasing and accelerating the digitization of large amounts of real world data (RWD) generated on individuals and patients. Originally published in Update magazine - August/September 2018....more
How to thrive amid uncertainty? This was the question we explored at the 35th FT Global Pharmaceutical and Biotechnology Conference. Here are five key industry trends and corresponding practical legal tips to help companies...more
Often lost in the cacophony of headlines surrounding rising health care costs is the promise that value-based contracting offers as a possible solution. In contrast to the traditional fee-for-service model, value-based...more
Top Five Healthcare Antitrust Trends to Watch in 2017 - Antitrust enforcement and litigation had a big year in 2016. In this article, we look back at the most significant cases for the healthcare industry over the last...more
1. Transition to a Trump Administration is top of the agenda - President-elect Donald Trump's DOJ and FTC transition team appointments and public short list of candidates to run the agencies indicate that antitrust...more
Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community, including regular updates on legislative initiatives from AGG’s Washington, DC...more
Just as with patient treatments, one size does not fit all when it comes to companies involved in personalized medicine. Each is unique in its mission, culture, and capabilities, and so it should come as no surprise that each...more